Otolaryngology (ENT), Allergy & Hearing Health Platform MSO
Integrate clinical ENT clinics with high-margin sublingual allergy immunotherapy, retail audiology hearing aid dispensaries, in-office sinus CT scanners, and surgical ASCs to capture 13x–16x EBITDA multiples.
Otolaryngology (ENT) represents one of the most lucrative multi-specialty consolidation targets in outpatient healthcare private equity. A premier ENT platform integrates clinical ear, nose, and throat surgical consultations with four high-margin ancillary revenue streams: in-office balloon sinuplasty and surgical ASC facility fees, in-house allergy scratch testing and custom sublingual immunotherapy (SLIT/SCIT) lab compounding, diagnostic in-office mini-CT scanning, and 100% cash-pay audiology hearing aid retail sales. However, navigating Stark Law In-Office Ancillary exceptions for imaging and allergy compounding requires sophisticated legal structuring. Kompanie LLP guides private equity platforms in architecting integrated ENT networks.
Deliverables
- Turnkey Friendly ENT Professional Corporation charters and bylaws.
- Stark-compliant In-Office Mini-CT Management and Equipment Lease.
- USP <797> Compliant Allergy Immunotherapy Laboratory Manual.
- Audiology Retail Sales Integration and staff incentive models.
Execution phases
- Stage 1: Ancillary Infrastructure & Stark Audit — Audit in-office CT scan billing (CPT 70486), verify sterile compounding protocols for allergy extracts, and evaluate audiology cash sales.
- Stage 2: MSO Centralization & Procurement Savings — Centralize balloon sinuplasty disposables and hearing aid manufacturer purchasing to capture 25%+ wholesale margin expansion.
- Stage 3: Regional ASC Consolidation & Platform Exit — Migrate pediatric myringotomy (tubes) and adult endoscopic sinus surgeries into platform ASCs, scaling EBITDA for secondary PE exit.
Diligence red flags
- In-office CT scanner operated in a hallway or unpartitioned space that fails the CMS Stark Same Building exclusive space test.
- Allergy antigen extract compounding (CPT 95165) performed by medical assistants without verified sterile USP <797> training or direct physician oversight.
- Audiologists receiving commissions directly tied to high-margin hearing aid sales models in violation of state consumer protection rules.
- Excessive out-of-network balloon sinuplasty billing triggering commercial payer fraud investigations and payment suspensions.
Frequently asked questions
Can an ENT practice legally sell hearing aids for cash through an MSO?
Yes. Audiology testing (CPT 92557) is billed to insurance, while hearing aid devices are sold directly to patients on a cash-pay retail basis ($2,000 to $6,000 per pair) with zero insurance billing friction, generating pure recurring margin.
How does an in-office sinus CT scanner impact ENT platform EBITDA?
An in-office cone-beam mini-CT scanner allows instant point-of-care sinus imaging (CPT 70486) during the initial patient visit, capturing $220+ in technical facility reimbursement per scan and immediately establishing surgical indications.